Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05786274 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Predicting Cerebrovascular Adverse Events Post Cardiac Surgery

Study acronym: PASCAL
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Mar 31, 2026 to Dec 31, 2026v4
  2. Re-verified, no change to tracked fieldsv3
  3. Trial status: Not Yet Recruiting to Recruiting Primary endpoints revised (3) · Study site revised · Secondary endpoints expanded, about 2 wordsv2 Show 3 more changesShow less
    • Primary endpoints revised (3)
    • Study site revised
    • Secondary endpoints expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aims of this study are: i) to assess cerebral autoregulation and autonomic control within the different phases of cardiac surgery with cardiopulmonary bypass; ii) to compare cerebral autoregulation measures derived via cerebral blood flow velocity estimated by transcranial Doppler device with simpler measurements derived from near infrared spectroscopy; iii) to develop a predictive model of postoperative cerebrovascular outcome (overt or silent stroke) based on the extracted indices.
Trial Details
NCT Number NCT05786274
Lead Sponsor IRCCS Policlinico S. Donato
Collaborators: University of Milan
Conditions Cardiac Disease
Enrollment 104 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov